Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Operating activities
Net loss	$ (85,091)	$ (66,936)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	14,517	9,237
Amortization of acquired intangible assets	7,100	300
Amortization of premiums and accretion of purchase discounts on investment securities	0	9
Non-cash lease expense	5,931	4,389
Non-cash settlement expense	1,226	0
Stock-based compensation	95,107	77,827
Change in fair value of warrants and preferred stock of related party equity investment	(166)	(3,235)
Revaluation of contingent consideration	6,120	0
Foreign exchange adjustment	258	138
Non-cash interest expense	(18)	(17)
Non-cash expense recovery	(596)	(361)
Changes in operating assets and liabilities:
Accounts receivable	(121,067)	(4,068)
Inventory	(2,278)	(5,623)
Operating lease right-of-use assets	255	0
Prepaid expenses and other assets	(17,064)	(9,354)
Accounts payable	21,880	2,379
Accrued compensation	98,233	17,035
Operating lease liabilities	(5,852)	(4,505)
Other accrued liabilities	12,105	26,866
Deferred revenue	11,882	671
Other long-term liabilities	(920)	0
Net cash provided by operating activities	40,171	44,452
Investing activities
Proceeds from maturity of investments	0	5,000
Purchases of property and equipment, net	(22,137)	(21,815)
Investment in related party	(10,000)	0
Net cash used in investing activities	(32,137)	(16,815)
Financing activities
Proceeds from exercise of stock options	3,863	544
Stock issuance costs	(105)	0
Net cash provided by financing activities	3,758	544
Net change in cash, cash equivalents and restricted cash	11,792	28,181
Cash, cash equivalents and restricted cash, beginning of period	1,076,140	945,587
Cash, cash equivalents and restricted cash, end of period	1,087,932	973,768
Supplemental disclosure of cash flow information:
Cash paid for interest	889	1,005
Non-cash investing and financing activities:
Purchases of property and equipment in accounts payable and accruals	18,216	4,223
Acquisition of warrants and warrants receivable	7,162	0
Consideration for business combination	(213)	0
Issuance of common stock for IPR&D milestone	774	0
Issuance of common stock for bonuses	47,026	32,063
Stock-based compensation included in capitalized software development costs	391	608
Foresight Diagnostics, Inc.
Adjustments to reconcile net loss to net cash provided by operating activities:
Amortization of acquired intangible assets	5,709	$ 0
Revaluation of contingent consideration	$ 7,200